Immuno-Oncology News

    Skip to content
    • Home
    • Immuno-Oncology
    • Categories
      • T cells
      • PD-1
      • Melanoma
      • Breast Cancer
      • Cancer Vaccines
      • FDA
    • About Us
    • Contact Us

    Profile

    April 8, 2014April 16, 2014
    adminby admin

    Home » Profile

    [symposium-profile]

    Receive our FREE Weekly Newsletter

    * indicates required

    Recent IO Articles

    • Pexa-Vec combination trial

      Combination of Pexa-Vec, Checkpoint Inhibitors to Be Tested in Advanced Colon Cancer Trial

      August 23, 2017

    • IND application for VBI-1901

      FDA Accepts Investigational New Drug Application for VBI’s Therapy to Treat Brain Cancer

      August 22, 2017

    • metabolic immuno-oncology

      American Society of Clinical Oncology Updates Guidelines for Treatment of Advanced Non-Small Cell Lung Cancer

      August 21, 2017

    • BPDCN Phase 1 Trial Begins

      First Patient with BPDCN Receives UCART123 Dose in Phase 1 Clinical Trial

      August 19, 2017

    • IFNAR1 solid cancers

      Scientists Examine How Anti-CTLA-4 and Anti-PD-1 Checkpoint-Blockade Therapies Fight Cancer Cells

      August 18, 2017

    You May Also Like…..

    Opdivo-Avastin Combo Holds Promise as Metastatic Renal Cell Carcinoma Therapy

    April 4, 2017

    Avastin

    Fred Hutchinson Researchers Present New Findings on Cancer Immunotherapy

    April 5, 2017

    new immunotherapy findings

    Researchers Find Way to Pinpoint Best Cancer-fighting T-cells

    March 7, 2017

    Identifying cancer-fighting cells
    Visit Immuno-Oncology News's profile on Pinterest.

    Immuno-Oncology News

    BioNews Services, LLC
    5307 E. Mockingbird Ln.
    5th Floor
    Dallas, TX 75206
    Email: info@bionewsservices.com
    Phone: 1-800-936-1363

    Recent Posts

    • Pexa-Vec combination trial

      Combination of Pexa-Vec, Checkpoint Inhibitors to Be Tested in Advanced Colon Cancer Trial

      August 23, 2017

    • IND application for VBI-1901

      FDA Accepts Investigational New Drug Application for VBI’s Therapy to Treat Brain Cancer

      August 22, 2017

    • metabolic immuno-oncology

      American Society of Clinical Oncology Updates Guidelines for Treatment of Advanced Non-Small Cell Lung Cancer

      August 21, 2017

    • BPDCN Phase 1 Trial Begins

      First Patient with BPDCN Receives UCART123 Dose in Phase 1 Clinical Trial

      August 19, 2017

    • About Immuno-Oncology News
    • Contact Us
    • Privacy Policy
    • Terms of Service

    Disclaimer:

    Immuno-Oncology News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2017 All rights reserved.